NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/16/2023
Back to search
Official data from USPTO
NJU DIAGNOSTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NJU DIAGNOSTICS
ST13
US500000097010544Class
42, 44
Filing
97010544
Registration
7051784
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
07/08/2023
Trademark type
Word
Nice classes
42, 44
Filing date
09/03/2021
Registration date
05/16/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2023
Last transaction
07/08/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
08/18/2015
First use in commerce
08/18/2015
Drawing code
4
Owner type
16
Owner location
Bloomfield, NJ, US
Examiner
TANNER, MICHAEL R
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
New Jersey Urology, LLC
Representatives
Mari-Elise Paul STITES & HARBISON PLLC
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pathology laboratory servicesproviding medical testing services and information in the field of cancer research and disease classificationgenetic testing for scientific research purposesproviding laboratory research services in the field of gene expressionnamely cancer biology; genetic sequencing and molecular testing for scientific research purposesproviding medical testing services and information in the field of cancer research and disease classificationgenetic testing for scientific research purposesproviding laboratory research services in the field of gene expressioncancer biology
Class 44
Genetic and molecular testing for medical diagnostic purposesgenetic testing for medical diagnostic and treatment purposesmedical testing services relating to the diagnosis and treatment of diseasemedical testing for diagnosis or treatment purposes; genetic sequencing and molecular testing for medical diagnostic and treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; pathology laboratory servicesgenetic testing for medical diagnostic and treatment purposesmedical testing services relating to the diagnosis and treatment of diseasemedical testing for diagnostic or treatment purposes
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2023
PUBO
PUBLISHED FOR OPPOSITION
02/28/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
01/03/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/03/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
01/03/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/29/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/28/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/28/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/26/2022
GNRT
NON-FINAL ACTION E-MAILED
05/26/2022
CNRT
NON-FINAL ACTION WRITTEN
05/26/2022
DOCK
ASSIGNED TO EXAMINER
05/18/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/22/2021
NWAP
NEW APPLICATION ENTERED
09/07/2021
Continuous trademark protection
Get notified about every new filing that threatens NJU DIAGNOSTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.